These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 23558342)
1. The experiences of patients with ascites secondary to cancer: a qualitative study. Day R; Mitchell T; Keen A; Perkins P Palliat Med; 2013 Sep; 27(8):739-46. PubMed ID: 23558342 [TBL] [Abstract][Full Text] [Related]
2. Patient experience of non-malignant ascites and its treatment: a qualitative study. Day R; Hollywood C; Durrant D; Perkins P Int J Palliat Nurs; 2015 Aug; 21(8):372-9. PubMed ID: 26312532 [TBL] [Abstract][Full Text] [Related]
3. Palliative long-term abdominal drains versus repeated drainage in individuals with untreatable ascites due to advanced cirrhosis: study protocol for a feasibility randomised controlled trial. Macken L; Mason L; Evans C; Gage H; Jordan J; Austin M; Parnell N; Cooper M; Steer S; Boles J; Bremner S; Lambert D; Crook D; Earl G; Timeyin J; Verma S Trials; 2018 Jul; 19(1):401. PubMed ID: 30053891 [TBL] [Abstract][Full Text] [Related]
4. Randomised clinical trial: palliative long-term abdominal drains vs large-volume paracentesis in refractory ascites due to cirrhosis. Macken L; Bremner S; Gage H; Touray M; Williams P; Crook D; Mason L; Lambert D; Evans CJ; Cooper M; Timeyin J; Steer S; Austin M; Parnell N; Thomson SJ; Sheridan D; Wright M; Isaacs P; Hashim A; Verma S Aliment Pharmacol Ther; 2020 Jul; 52(1):107-122. PubMed ID: 32478917 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of reinfusion of concentrated ascitic fluid for malignant ascites: a concept-proof study. Hanada R; Yokomichi N; Kato C; Miki K; Oyama S; Morita T; Kawahara R Support Care Cancer; 2018 May; 26(5):1489-1497. PubMed ID: 29168037 [TBL] [Abstract][Full Text] [Related]
6. Outcomes of permanent peritoneal ports for the management of recurrent malignant ascites. Coupe NA; Cox K; Clark K; Boyer M; Stockler M J Palliat Med; 2013 Aug; 16(8):938-40. PubMed ID: 23734592 [TBL] [Abstract][Full Text] [Related]
7. Malignant ascites symptom cluster in patients referred for paracentesis. Husain A; Bezjak A; Easson A Ann Surg Oncol; 2010 Feb; 17(2):461-9. PubMed ID: 19866240 [TBL] [Abstract][Full Text] [Related]
8. Sonographically guided paracentesis for palliation of symptomatic malignant ascites. Ross GJ; Kessler HB; Clair MR; Gatenby RA; Hartz WH; Ross LV AJR Am J Roentgenol; 1989 Dec; 153(6):1309-11. PubMed ID: 2479242 [TBL] [Abstract][Full Text] [Related]
9. Palliative long-term abdominal drains in refractory ascites due to end-stage liver disease: A case series. Macken L; Joshi D; Messenger J; Austin M; Tibble J; Mason L; Verma S Palliat Med; 2017 Jul; 31(7):671-675. PubMed ID: 27707955 [TBL] [Abstract][Full Text] [Related]
10. Palliative Long-Term Abdominal Drains Versus Large Volume Paracentesis in Refractory Ascites Due to Cirrhosis (REDUCe Study): Qualitative Outcomes. Cooper M; Pollard A; Pandey A; Bremner S; Macken L; Evans CJ; Austin M; Parnell N; Steer S; Thomson S; Hashim A; Mason L; Verma S J Pain Symptom Manage; 2021 Aug; 62(2):312-325.e2. PubMed ID: 33348031 [TBL] [Abstract][Full Text] [Related]
11. Consultations between nurse prescribers and patients with diabetes in primary care: A qualitative study of patient views. Stenner KL; Courtenay M; Carey N Int J Nurs Stud; 2011 Jan; 48(1):37-46. PubMed ID: 20627198 [TBL] [Abstract][Full Text] [Related]
12. Placement of a permanent tunneled peritoneal drainage catheter for palliation of malignant ascites: a simplified percutaneous approach. Barnett TD; Rubins J J Vasc Interv Radiol; 2002 Apr; 13(4):379-83. PubMed ID: 11932368 [TBL] [Abstract][Full Text] [Related]
13. Paracentesis for cancer-related ascites in palliative care: An international, prospective cohort study. Seah DS; Wilcock A; Chang S; Sousa MS; Sinnarajah A; Teoh CO; Allan S; Chye R; Doogue M; Hunt J; Agar M; Currow DC Palliat Med; 2022 Oct; 36(9):1408-1417. PubMed ID: 36113139 [TBL] [Abstract][Full Text] [Related]
14. Permanent peritoneal ports for the management of recurrent malignant ascites: a retrospective review of safety and efficacy. Chen BS; Wong SHC; Hawkins S; Huggins L Intern Med J; 2018 Dec; 48(12):1524-1528. PubMed ID: 30517990 [TBL] [Abstract][Full Text] [Related]
15. Effective palliation of refractory ascites in cirrhosis is challenging. Abbott J; Verma S; Saksena S Int J Palliat Nurs; 2024 Jun; 30(6):286-293. PubMed ID: 38913640 [TBL] [Abstract][Full Text] [Related]
16. A randomized trial of paracentesis plus intraperitoneal tumor necrosis factor-alpha versus paracentesis alone in patients with symptomatic ascites from recurrent ovarian carcinoma. Hirte HW; Miller D; Tonkin K; Findlay B; Capstick V; Murphy J; Buckman R; Carmichael J; Levine M; Hill W Gynecol Oncol; 1997 Jan; 64(1):80-7. PubMed ID: 8995552 [TBL] [Abstract][Full Text] [Related]
17. Safety, cost-effectiveness and feasibility of daycase paracentesis in the management of malignant ascites with a focus on ovarian cancer. Harding V; Fenu E; Medani H; Shaboodien R; Ngan S; Li HK; Burt R; Diamantis N; Tuthill M; Blagden S; Gabra H; Urch CE; Moser S; Agarwal R Br J Cancer; 2012 Sep; 107(6):925-30. PubMed ID: 22878372 [TBL] [Abstract][Full Text] [Related]
18. Management of symptomatic ascites in recurrent ovarian cancer patients using an intra-abdominal semi-permanent catheter. Iyengar TD; Herzog TJ Am J Hosp Palliat Care; 2002; 19(1):35-8. PubMed ID: 12171424 [TBL] [Abstract][Full Text] [Related]
19. Long-term semi-permanent catheter use for the palliation of malignant ascites. Brooks RA; Herzog TJ Gynecol Oncol; 2006 May; 101(2):360-2. PubMed ID: 16499957 [TBL] [Abstract][Full Text] [Related]
20. Peritoneal catheter site metastasis in a patient with advanced ovarian cancer. Ramirez I; Bansal N; Hoffman M Am J Hosp Palliat Care; 2012 May; 29(3):241-2. PubMed ID: 21606122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]